Country: Australia

Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical and GLP toxicology laboratory, has been delivering bioanalytical services for non-clinical studies and clinical trials for over 28 years. Agilex boasts world-class facilities equipped with cutting-edge equipment, including 17 Sciex API LC-MS/MS mass spectrometers to measure small molecule drugs, including novel chemical entities, nucleotides, enantiomers, peptides. Their immunoassay and immunobiology laboratories feature state-of-the-art equipment for large molecule bioanalysis, such as Gyrolab xPlore, MSD Quickplex 120, BD FACSymphony A3 flow cytometers, and BioRad droplet digital quantitative real-time analysers for RNA, siRNA, and miRNA clinical trials, including vaccines and gene therapy trials. Agilex also offers a range of rodent toxicology, including non-GLP and GLP toxicology services and pharmacokinetics studies, to support preclinical through to early/late-phase clinical programs at its custom-built, state-of-the-art GLP facility in Brisbane, Australia. With expertise in all types of molecules, laboratory species, routes of administration, and non-clinical studies, in addition to multiple certifications such as ISO/IEC17025 accreditation and OECD GLP recognition with NATA, Agilex ensures the highest quality standards for seamless end-to-end testing from preclinical to clinical analysis. As a proud member of the Healius network and through its partnership with global laboratory provider SGS, Agilex Biolabs offers a one-stop-shop package to support multi-region drug development from preclinical to late phase, accelerating hundreds of nonclinical and clinical trials for sponsors from the USA, APAC, and Europe.